21531 ⎘
Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus; Organic compounds; Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
Metolazone emulsion formulation
#2NOVEL DEUTERIUM SUBSTITUTED POSITRON EMISSION TOMOGRAPHY (PET) IMAGING AGENTS AND THEIR PHARMACOLOGICAL APPLICATION
#3Deuterium substituted positron emission tomography (PET) imaging agents and their pharmacological application
#4Metolazone emulsion formulation
#5Deuterium substituted positron emission tomography (PET) imaging agents and their pharmacological application
#6Probes for imaging huntingtin protein
#7Alpha-synuclein ligands
#8RADIOLABELED GNRH ANTAGONISTS AS PET IMAGING AGENTS
#9HETEROARYL INHIBITORS OF PDE4
#10Aryloxyanilide imaging agents
#11STABILIZATION OF RADIOIODINATED AND ASTATINATED PHARMACEUTICALS AND IMAGING AGENTS
#12CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING
#13Aryloxyanilide imaging agents
#14MYELIN DETECTION USING BENZOFURAN DERIVATIVES
#15Myelin detection using benzofuran derivatives
#16AURONE DERIVATIVE-CONTAINING COMPOSITION FOR DIAGNOSIS
#17DETECTING SOLUBLE A-BETA
#18Contrast agents for myocardial perfusion imaging
#19HETEROCYCLIC INDENE DERIVATIVES AND THEIR RADIOISOTOPE LABELED COMPOUNDS FOR IMAGING BETA-AMYLOID DEPOSITION
#20Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein
#21Contrast agents for myocardial perfusion imaging
#22Compounds for imaging alzheimer's disease
#23Fused pyrrolecarboxamides: GABA brain receptor ligands
#24Methods of treating diseases responsive to induction of apoptosis and screening assays